Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib
- PMID: 33709492
- DOI: 10.1002/hep.31794
Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib
References
-
- Tsuchiya A, Kubota T, Takizawa K, Yamada K, Wakai T, Matsuda Y, et al. Successful treatment in a case of massive hepatocellular carcinoma with paraneoplastic syndrome. Case Rep Gastroenterol 2009;3:105-110.
-
- Parperis K, Constantinidou A, Panos G. Paraneoplastic arthritides: insights to pathogenesis, diagnostic approach, and treatment. J Clin Rheumatol. 2019 Nov 15. https://doi.org/10.1097/RHU.0000000000001202. [Epub ahead of print]
-
- Manger B, Schett G. Rheumatic paraneoplastic syndromes-a clinical link between malignancy and autoimmunity. Clin Immunol 2018;186:67-70.
-
- Schultz H, Krenn V, Tony HP. Oligoarthritis mediated by tumor-specific T lymphocytes in renal-cell carcinoma. N Engl J Med 1999;341:290-291.
-
- Kudo M, Ueshima K, Chan S, Minami T, Chishina H, Aoki T, et al. Lenvatinib as an initial treatment in patients with intermediated-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: a proof-of-concept study. Cancers 2019;11:1084.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
